| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | Oct 24, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 46.3 | -2,520 | -1.24% | ✗ | $48K |
| Oct 8, 2025 | Oct 10, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 48.8 | -1,585 | -0.77% | ✗ | $25.8K |
| Jul 23, 2025 | Jul 25, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -2,805 | -1.35% | ✗ | $50.9K |
| Jul 9, 2025 | Jul 11, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 48.8 | -1,519 | -0.73% | ✗ | $26.2K |
| Apr 23, 2025 | Apr 25, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 48.8 | -1,925 | -0.91% | ✗ | $28.5K |
| Apr 9, 2025 | Apr 11, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -5,004 | -2.31% | ✗ | $65K |
| Jan 22, 2025 | Jan 24, 2025 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -2,195 | -1.54% | ✗ | $51.8K |
| Oct 23, 2024 | Oct 25, 2024 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -2,740 | -1.89% | ✗ | $80.9K |
| Jul 24, 2024 | Jul 26, 2024 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -2,813 | -1.90% | ✗ | $78.1K |
| Apr 24, 2024 | Apr 26, 2024 | Immunovant, Inc. | Chief Technology Officer | Sell | 42.5 | -7,239 | -4.67% | ✗ | $209.2K |